NCT02068599 - A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee | Biotech Hunter

Enrollment

389

Participants

Timeline

Start Date

April 14, 2014

Primary Completion Date

April 6, 2015

Study Completion Date

May 4, 2015

Conditions

Osteoarthritis of the Knee

Interventions

DRUG

TV-45070

TV-45070 ointment administered twice a day (morning and evening) to target knee. Participants were provided with a laminated instruction sheet including pictures that both described and illustrated how the ointment was to be spread over the entire knee anteriorly, medially, and laterally in a thin layer that fully covered the area. The ointment was gently massaged into the skin.

DRUG

Placebo

Placebo ointment matching active intervention administered twice a day (morning and evening) to target knee. Participants were provided with a laminated instruction sheet including pictures that both described and illustrated how the ointment was to be spread over the entire knee anteriorly, medially, and laterally in a thin layer that fully covered the area. The ointment was gently massaged into the skin.

Trial Locations (42)

Unknown

Teva Investigational Site 12217, Anaheim

Teva Investigational Site 12244, Anaheim

Teva Investigational Site 12252, Cerritos

Teva Investigational Site 13009, Cerritos

Teva Investigational Site 12233, El Cajon

Teva Investigational Site 12240, Lomita

Teva Investigational Site 12251, Sacramento

Teva Investigational Site 12234, Spring Valley

Teva Investigational Site 12256, Clearwater

Teva Investigational Site 12241, DeLand

Teva Investigational Site 12246, Eustis

Teva Investigational Site 12231, Fort Myers

Teva Investigational Site 12216, Hialeah

Teva Investigational Site 12230, Jacksonville

Teva Investigational Site 12220, Miami

Teva Investigational Site 12221, Oldsmar

Teva Investigational Site 12226, Orlando

Teva Investigational Site 12237, Orlando

Teva Investigational Site 12255, Ormond Beach

Teva Investigational Site 12225, Plantation

Teva Investigational Site 12229, Sanford

Teva Investigational Site 12235, Tampa

Teva Investigational Site 12253, Atlanta

Teva Investigational Site 12250, Marietta

Teva Investigational Site 12243, Evansville

Teva Investigational Site 12238, Overland Park

Teva Investigational Site 12218, New Orleans

Teva Investigational Site 12245, Watertown

Teva Investigational Site 12228, Bingham Farms

Teva Investigational Site 12242, Hazelwood

Teva Investigational Site 12249, St Louis

Teva Investigational Site 12223, Omaha

Teva Investigational Site 12219, New York

Teva Investigational Site 12239, Charlotte

Teva Investigational Site 12248, Raleigh

Teva Investigational Site 12247, Winston-Salem

Teva Investigational Site 12254, Winston-Salem

Teva Investigational Site 12224, Cincinnati

Teva Investigational Site 12236, Memphis

Teva Investigational Site 12232, Dallas

Teva Investigational Site 12227, Plano

Teva Investigational Site 12222, Charlottesville

All Listed Sponsors

lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY